A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Status:
Completed
Trial end date:
2018-09-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether CC-220 is effective for the treatment of
skin, joint and serological manifestations of systemic lupus erythematosus.